Showing results (211-220 of 267) with videos related to

Sort By:
Pageof 27
Molecular Pharmaceutics|April 8, 2009
Synthesis and biological evaluation of a bioresponsive and endosomolytic siRNA-polymer conjugateMartin Meyer, Christian Dohmen, Alexander Philipp, et al.
Antimicrobial Agents and Chemotherapy|July 20, 2011
Molecular basis for the selectivity of antituberculosis compounds capreomycin and viomycinRashid Akbergenov, Dmitri Shcherbakov, Tanja Matt, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|June 24, 2010
Neurophysiological evidence of impaired musical sound perception in cochlear-implant usersPascale Sandmann, Andrea Kegel, Tom Eichele, et al.
Journal of Pineal Research|December 30, 2020
Changing color and intensity of LED lighting across the day impacts on circadian melatonin rhythms and sleep in healthy menOliver Stefani, Marlène Freyburger, Simon Veitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2002
Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term resultsClaus Rödel, Gerhard G Grabenbauer, Reinhard Kühn, et al.
Open Mind : Discoveries in Cognitive Science|July 7, 2023
The Agent Preference in Visual Event ApprehensionArrate Isasi-Isasmendi, Caroline Andrews, Monique Flecken, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|June 15, 2012
Survival of ovarian cancer patients in Germany in the early 21st century: a period analysis by age, histology, laterality, and stageTianhui Chen, Lina Jansen, Adam Gondos, et al.
Life (Basel, Switzerland)|May 26, 2018
Molecular Evolution in a Peptide-Vesicle SystemChristian Mayer, Ulrich Schreiber, María J Dávila, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 16, 2015
Integrated prostate cancer centers might cause an overutilization of radiotherapy for low-risk prostate cancer: A comparison of treatment trends in the United States and Germany from 2004 to 2011Benjamin Hager, Klaus Kraywinkel, Bastian Keck, et al.
Pageof 27